R. Haaseth

发表

Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.

F. Porreca, R. Craft, S. Henley, 1995, The Journal of pharmacology and experimental therapeutics.

Conformational Determinants of Agonist versus Antagonist Properties of [d-Pen2,d-Pen5]Enkephalin (DPDPE) Analogs at Opioid Receptors. Comparison of X-ray Crystallographic Structure, Solution 1H NMR Data, and Molecular Dynamic Simulations of [l-Ala3]DPDPE and [d-Ala3]DPDPE

C. George, J. Flippen-Anderson, V. Hruby, 1996 .

Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs.

V. Hruby, A. Lipkowski, A. Misicka, 1993, The Journal of pharmacology and experimental therapeutics.

Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity.

R. Tallarida, V. Hruby, F. Porreca, 1992, Life sciences.

Practical protocols for efficient solid-phase peptide synthesis: Minimization of side-reactions

F. Albericio, A. El‐Faham, S. Kates, 1995 .

Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.

V. Hruby, A. Lipkowski, A. Misicka, 1993, The Journal of pharmacology and experimental therapeutics.

Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.

H. Mosberg, F. Porreca, J. L. Vaught, 1989, European journal of pharmacology.

Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.

H. Mosberg, P. Portoghese, M. Sultana, 1994, European journal of pharmacology.

Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.

R. Horváth, V. Hruby, R. Knapp, 1994, The Journal of pharmacology and experimental therapeutics.

Para-substituted phenylalanine-4 analogues of [L-Ala3]DPDPE: highly selective delta opioid receptor ligands.

V. Hruby, H. Yamamura, T. Zalewska, 2009, The journal of peptide research : official journal of the American Peptide Society.

Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.

V. Hruby, A. Lipkowski, A. Misicka, 1993, European journal of pharmacology.

Interaction of [ D-Pen 2 , 0-PenS ] enkephalin and [ DAla 2 , Glu 4 ] deltorphin with-opioid receptor subtypes in vivo

H. Mosberg, P. Portoghese, M. Sultana, 2002 .

Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.

V. Hruby, T. Burks, P. Davis, 1991, Life sciences.

Role of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalin.

H. Akil, H. Mosberg, A. Mansour, 2009, International journal of peptide and protein research.

The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice.

K. Kurachi, D. Allen, S. Ethier, 2000, The Journal of clinical investigation.

Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.

H. Mosberg, C. Smith, F. Medzihradsky, 2009, International journal of peptide and protein research.

Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin.

H. Mosberg, M. Reichman, D. Hammond, 1992, Journal of medicinal chemistry.

Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.

F. Porreca, B. de Costa, R. Haaseth, 1993, The Journal of pharmacology and experimental therapeutics.

Opioid peptide interactions with lipid bilayer membranes.

V. Hruby, R. Haaseth, T. Matsunaga, 1992, Biochimica et biophysica acta.

Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.

H. Mosberg, C. Smith, D. Heyl, 1990, Molecular Pharmacology.

A Simple and Concrete Model for the Introduction of Cell Theory in the Secondary School

R. Haaseth, R. Royer, 1986 .